Navigation Links
Sensus Healthcare Announces Its Exhibitor Attendance at the 9th Annual South Beach Symposium™
Date:2/17/2011

BOCA RATON, Fla., Feb. 17, 2011 /PRNewswire/ -- Sensus Healthcare is proud to announce their exhibitor participation in the 9th Annual South Beach Symposium™ in Miami Beach, FL on February 17-21, 2011.  The South Beach Symposium™ is a comprehensive session with three non-overlapping tracks in clinical dermatology, aesthetics, and practice management. Sensus Healthcare is featuring superficial radiotherapy (SRT) with their SRT-100™ advanced platform as a complimentary tool for the dermatologists and Mohs surgeons and as a non-surgical option for their patients. Dr. Gary D. Monheit is a keynote speaker at the symposium, reviewing the advantages of SRT and its pertinence and benefits to the dermatology practices and non-melanoma skin cancer patients, with a presentation titled "Radiation Therapy in the Treatment of Skin Cancer: Back Home to Dermatology" on Sunday February 20, 2011 at 9:00AM Eastern. Visit Sensus (booth #416) at the 9th South Beach Symposium™ to be held at the Loews Miami Beach Hotel to learn about the SRT-100™ low-dose non-invasive superficial radiotherapy (SRT) non-melanoma skin cancer therapy solution.

(Logo: http://photos.prnewswire.com/prnh/20110124/FL34943LOGO)

"Sensus is very excited to be participating in this year's South Beach Symposium. We are looking forward to meeting with key leaders of Dermatology as we present the SRT-100™ as a compliment to their existing array of skin cancer treatments" –Steve Cohen (Vice President of Strategic Initiatives, Sensus Healthcare)

About Sensus Healthcare:Sensus Healthcare specializes in making proven non-melanoma skin cancer solutions more accessible to patients. Our dedicated superficial radiation therapy (SRT) systems are designed specifically to provide an alternative to surgical procedures for basal cell and squamous cell carcinomas. Our mobile, compact SRT-100™ systems are used widely by oncologists and dermatologists to bring non-melanoma skin cancer treatment to more patients in more settings. We also offer a professional skin care line, Sensus Skin Solutions™, through our physician SRT-100™ users for their patients.

About South Beach Symposium™:The South Beach Symposium is designed to meet the needs of physicians, nurses and professional staff members of medical practices specializing in dermatology, plastic surgery, cosmetic surgery, pediatric dermatology and other dermatologic medical procedures. The symposium features three non–overlapping CME tracks – the South Beach Clinical Dermatology Symposium, the South Beach Aesthetics Symposium and the Practice Management Symposium.Contact:Vicky PerezPublic Relations561-922-5808 Ext 108vicky@sensushealthcare.com
'/>"/>

SOURCE Sensus Healthcare
Copyright©2010 PR Newswire.
All rights reserved

Related biology technology :

1. Sensus Healthcare Announces the Formation of a Medical Advisory Board
2. Sensus Healthcare Announces New Professional Skin Care Line - Sensus Skin Solutions™
3. Sensus Healthcare Announces Strategic Partnership With Flagship Solutions Group
4. Genomic Health Reports Favorable Commentary on Value of Multigene Assays From the St. Gallen Expert Consensus Meeting on the Primary Treatment of Early Breast Cancer
5. GPhA Statement on the Introduction of the Bipartisan Biogenerics Consensus Bill: Promoting Innovation and Access to Life-Saving Medicine Act
6. New consensus on work-related asthma
7. Shionogi-ViiV Healthcare Starts Phase III Trial for 572-Trii Fixed-Dose Combination HIV Therapy
8. Anthera Pharmaceuticals to Present at the 29th Annual J.P. Morgan Healthcare Conference
9. Biodel Inc. to Present at 29th Annual JPMorgan Healthcare Conference on January 13th, 2011
10. Orexigen® Therapeutics to Present at JP Morgan Healthcare Conference
11. Cellular Dynamics International to Present at 29th Annual JPMorgan Healthcare Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/28/2017)...  Xencor, Inc. (NASDAQ: XNCR), a clinical-stage biopharmaceutical company ... autoimmune diseases, asthma and allergic diseases and cancer, ... and full year ended December 31, 2016 and ... and clinical highlights. "During 2016, we ... by starting five clinical trials across our XmAb ...
(Date:2/28/2017)... ... February 28, 2017 , ... FireflySci is a small cuvette manufacturer ... late 2014, FFS had a mission to bring affordable and quality lab equipment to ... product that gives a lab everything needed to get started with using cuvettes. , ...
(Date:2/28/2017)... ... February 28, 2017 , ... ACEA Biosciences, a pioneer in cell analysis instrumentation ... Dr. Roger (Feng) Luo as the new Vice President of Global Clinical Development. ... drug companies, Dr. Luo will now team with Dr. Li Xu, Chief Medical Officer, ...
(Date:2/28/2017)... ... February 28, 2017 , ... GigaGen ... from millions-diverse immune repertoires, today announced a strategic partnership with Trianni, Inc. ... to express human antibodies. The partnership will use GigaGen technology to discover immuno-oncology ...
Breaking Biology Technology:
(Date:2/21/2017)... February 21, 2017 Der weltweite ... wachsen. Nach einem Gespräch mit mehr als 50 Vertretern aus ... zu überwinden gilt, um diese Prognose zu realisieren. ... ... Mobilisierung der finanziellen Mittel für die Biobank, die Implementierung ...
(Date:2/13/2017)... 2017 Former 9/11 Commission border counsel and ... Janice Kephart of Identity Strategy Partners, LLP, today ... "Executive Order: Protecting the Nation From Foreign Terrorist ... "As President Trump,s ,Travel Ban, Executive Order gains ... banned the travel ban, it is important that our ...
(Date:2/8/2017)... 7, 2017  Aware, Inc. (NASDAQ: AWRE ), ... financial results for its quarter and year ended December 31, ... 2016 was $3.9 million compared to $6.9 million in the ... of 2016 was $0.6 million compared to $2.6 million in ... quarter of 2016 was $0.5 million, or $0.02 per diluted ...
Breaking Biology News(10 mins):